(Q30234324)

11 June 2017

1 reference

title

Reducing the costs of chronic kidney disease while delivering quality health care: a call to action (English)

1 reference

chronic renal insufficiency

11 June 2017

1 reference

1

Raymond Vanholder

1 reference

11 June 2017

Judith J Gout-Zwart

5

1 reference

11 June 2017

Rachael L Morton

7

1 reference

11 June 2017

Marcello Tonelli

10

1 reference

11 June 2017

11

Wim Van Biesen

1 reference

11 June 2017

6

Norbert Lameire

1 reference

11 June 2017

2

Lieven Annemans

1 reference

11 June 2017

4

Ron Gansevoort

1 reference

11 June 2017

Edwina Brown

3

1 reference

11 June 2017

Rainer Oberbauer

8

1 reference

11 June 2017

Maarten J Postma

9

1 reference

11 June 2017

Carmine Zoccali

12

1 reference

11 June 2017

European Kidney Health Alliance

13

1 reference

11 June 2017

language of work or name

English

0 references

publication date

30 May 2017

1 reference

Nature Reviews Nephrology

11 June 2017

1 reference

Economic evaluation of dialysis therapies

11 June 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Estimating the financial cost of chronic kidney disease to the NHS in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Epidemiology: Global Burden of Disease Study 2013 reports that disability caused by CKD is increasing worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Clinical management of the uraemic syndrome in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cost to government and society of chronic kidney disease stage 1-5: a national cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Recent advances: nephrology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Chronic kidney disease: global dimension and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Renal replacement therapy: how can we contain the costs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The developmental origins of health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

On the Concept of Health Capital and the Demand for Health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The Population Health Model (POHEM): an overview of rationale, methods and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Chronic kidney disease and life expectancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Maternal Smoking during Pregnancy, Household Smoking after the Child's Birth, and Childhood Proteinuria at Age 3 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cost-effectiveness analysis of renal replacement therapy in Austria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

A study of the quality of life and cost-utility of renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Increasing the pool of deceased donor organs for kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

A step toward solving the long-term care dilemma for living kidney donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Patients' perceptions of information and education for renal replacement therapy: an independent survey by the European Kidney Patients' Federation on information and support on renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The Declaration of Istanbul on Organ Trafficking and Transplant Tourism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

An international comparison of deceased and living organ donation/transplant rates in opt-in and opt-out systems: a panel study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Preferences for Policy Options for Deceased Organ Donation for Transplantation: A Discrete Choice Experiment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The impact of presumed consent legislation on cadaveric organ donation: A cross-country study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Development of the Croatian model of organ donation and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Expanded criteria donors for kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Does pre-emptive transplantation versus post start of dialysis transplantation with a kidney from a living donor improve outcomes after transplantation? A systematic literature review and position statement by the Descartes Working Group and ERBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Global trends in the rates of living kidney donation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Dialysis Vintage and Outcomes after Kidney Transplantation: A Retrospective Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Living donor practices in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Reimbursement of dialysis: a comparison of seven countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The possible impact of the US prospective payment system ("bundle") on the growth of peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Belgium's mixed private/public health care system and its impact on the cost of end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cost of peritoneal dialysis and haemodialysis across the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Nephrology in Africa--not yet uhuru

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The economic considerations of patients and caregivers in choice of dialysis modality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Dialysis: Choice of dialysis--what to do with economic incentives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

International study of health care organization and financing: development of renal replacement therapy in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Universal coverage of renal dialysis in Thailand: promise, progress, and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Pro and con arguments in using alternative dialysis regimens in the frail and elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Assisted Peritoneal Dialysis as an Alternative to In-Center Hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Quality of Life and Physical Function in Older Patients on Dialysis: A Comparison of Assisted Peritoneal Dialysis with Hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Assisted Peritoneal Dialysis for Older People with End-Stage Renal Disease: The French and Danish Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Consequences of late referral on patient outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The effect of longevity on spending for acute and long-term care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Population ageing in the United States of America: implications for public programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

A population-based study of the incidence and outcomes of diagnosed chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Clinical practices and outcomes in elderly hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Early dialysis initiation and rates and timing of withdrawal from dialysis in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Dialysis in late life: benefit or burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Significance of frailty among dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Functional status of elderly adults before and after initiation of dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Decisions about Renal Replacement Therapy in Patients with Advanced Kidney Disease in the US Department of Veterans Affairs, 2000-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Supportive Care: Comprehensive Conservative Care in End-Stage Kidney Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Dialysis or conservative care for frail older patients: ethics of shared decision-making

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

A randomized, controlled trial of early versus late initiation of dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Effective CKD care in European countries: challenges and opportunities for health policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

A closer look at the economic argument for disease prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Priorities among effective clinical preventive services: methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Projected reduction in healthcare costs in Belgium after optimization of iodine intake: impact on costs related to thyroid nodular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Healthcare Costs Associated with an Adequate Intake of Sugars, Salt and Saturated Fat in Germany: A Health Econometrical Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cost and health consequences of reducing the population intake of salt

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Need for differential discounting of costs and health effects in cost effectiveness analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Differential time preferences for money and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Preventing fatal diseases increases healthcare costs: cause elimination life table approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Economics of chronic diseases protocol: cost-effectiveness modelling and the future burden of non-communicable disease in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Levels of physical activity among adults 18-64 years old in 28 European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Burden of Sickness Absence Due to Chronic Disease in the Dutch Workforce from 2007 to 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Preventing chronic diseases: how many lives can we save?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Economics of smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Association between smoking and chronic renal failure in a nationwide population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Association between smoking and chronic kidney disease: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Smoking as a risk factor for end-stage renal failure in men with primary renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Association of age and BMI with kidney function and mortality: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Population-Attributable Fractions of Modifiable Lifestyle Factors for CKD and Mortality in Individuals With Type 2 Diabetes: A Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Chronic kidney disease associated with environmental toxins and exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Health, life expectancy, and health care spending among the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Population based study of social and productive activities as predictors of survival among elderly Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

"The high cost of dying": what do the data show? 1984.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Ageing of population and health care expenditure: a red herring?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Global sodium consumption and death from cardiovascular causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Urinary Sodium and Potassium Excretion and CKD Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Sodium intake, ACE inhibition, and progression to ESRD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Dietary salt reduction in hypertension--what is the evidence and why is it still controversial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Dietary Sodium and Cardiovascular Disease Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Dietary Sodium and Cardiovascular Disease Risk--Measurement Matters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Are physical activity interventions in primary care and the community cost-effective? A systematic review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Exercise Evaluation Randomised Trial (EXERT): a randomised trial comparing GP referral for leisure centre-based exercise, community-based walking and advice only.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Obesity and overweight in Canada: an updated cost-of-illness study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Economic burden of obesity and its comorbidities in Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The potential health and economic effect of a Body Mass Index decrease in the overweight and obese population in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Mortality, morbidity and costs attributable to smoking in Germany: update and a 10-year comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

An analysis of the economic impact of smoking cessation in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Lifetime medical costs of obesity: prevention no cure for increasing health expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Chronic kidney disease as cause of cardiovascular morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

To treat or not to treat? Cost-effectiveness of ace inhibitors in non-diabetic advanced renal disease - a Dutch perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Antihypertensive treatment with and without benazepril in patients with chronic renal insufficiency: a US economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cost-effectiveness of primary screening for CKD: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Population based screening for chronic kidney disease: cost effectiveness study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Screening for proteinuria in US adults: a cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Baseline albuminuria predicts the efficacy of blood pressure-lowering drugs in preventing cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The management of older adults with a low eGFR: moving toward an individualized approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Slowing the progression of chronic renal failure: economic benefits and patients' perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Consent for research with biological samples: one-time general consent versus a gift model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Measured GFR as a confirmatory test for estimated GFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Current issues in measurement and reporting of urinary albumin excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Added value of screening for CKD among the elderly or persons with low socioeconomic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Treatment of Anemia in Patients With Heart Disease: A Clinical Practice Guideline From the American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Screening: Screening for kidney disease--a lost opportunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Risk Prediction for Early CKD in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cost-effectiveness of enzyme replacement therapy for Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

How much will Herceptin really cost?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Health economics and European Renal Best Practice--is it time to bring health economics into evidence-based guideline production in Europe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Hospital-acquired acute kidney injury: an analysis of nadir-to-peak serum creatinine increments stratified by baseline estimated GFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Acute kidney injury: an increasing global concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Acute kidney injury-epidemiology, outcomes and economics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The economic impact of acute kidney injury in England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Acute kidney injury and chronic kidney disease as interconnected syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Does AKI truly lead to CKD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The Role of Acute Kidney Injury in Chronic Kidney Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Increasing consumption of ultra-processed foods and likely impact on human health: evidence from Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Processed foods: contributions to nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Trends in consumption of ultra-processed foods and obesity in Sweden between 1960 and 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Do healthier foods and diet patterns cost more than less healthy options? A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Nutrition Labeling to Prevent Obesity: Reviewing the Evidence from Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Consumer understanding and use of nutrition labelling: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Nutrition labels on pre-packaged foods: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Use of food nutrition labels is associated with lower fat intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Mediterranean diet and cardiodiabesity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Development of international criteria for a front of package food labelling system: the International Choices Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Modelling of usual nutrient intakes: potential impact of the choices programme on nutrient intakes in young dutch adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Food label use and awareness of nutritional information and recommendations among persons with chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Use and understanding of nutrition information on food labels in six European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Dietary and fluid restrictions in CKD: a thematic synthesis of patient views from qualitative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Relationship between Health Literacy and Kidney Function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Limited health literacy is associated with low glomerular filtration in the Chronic Renal Insufficiency Cohort (CRIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Investing in youth tobacco control: a review of smoking prevention and control strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The Effectiveness of Health Literacy Oriented Programs on Physical Activity Behaviour in Middle Aged and Older Adults with Type 2 Diabetes: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

School food policy at Dutch primary schools: room for improvement? Cross-sectional findings from the INPACT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The effects of the Danish saturated fat tax on food and nutrient intake and modelled health outcomes: an econometric and comparative risk assessment evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Reinvesting in health post-2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of r

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cost-Effectiveness of Initiating Dialysis Early: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Health expenditure growth: reassessing the threat of ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The organization and financing of kidney dialysis and transplant care in the United States of America

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Australian consumer perspectives on dialysis: First national census

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Home care assistance and the utilization of peritoneal dialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR <45 mL/min/1.73 m2)

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

31 March 2020

12 December 2020

The deadly risk of late referral

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Pre-dialysis hospital use and late referrals in incident dialysis patients in England: a retrospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The initiation of renal-replacement therapy--just-in-time delivery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Early dialysis of no benefit to the patient or the health care system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The prevention challenge and opportunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Screening for chronic kidney disease: U.S. Preventive Services Task Force recommendation statement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

The food industry and self-regulation: standards to promote success and to avoid public health failures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

BMA calls for 20% sugar tax to subsidise cost of fruit and vegetables

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.63

Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians

31 March 2020

1 reference

12 December 2020

Association between sodium intakes with the risk of chronic kidney disease: evidence from a meta-analysis

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease

1 reference

12 December 2020

Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline

1 reference

12 December 2020

Peritoneal dialysis in Ontario: a natural experiment in physician reimbursement methodology

1 reference

12 December 2020

Improving outcomes of acute kidney injury survivors

1 reference

12 December 2020

Potential impact of population-based colorectal cancer screening in Canada.

1 reference

12 December 2020

Cost of renal replacement: how to help as many as possible while keeping expenses reasonable?

1 reference

12 December 2020

Corner Store Inventories, Purchases, and Strategies for Intervention: A Review of the Literature

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2017.63

1 reference

11 June 2017

1 reference